PsyPost on MSN
This specialized cognitive training triggers neurobiological changes and lowers cortisol
A new study published in Psychological Medicine has found that a specific type of cognitive training can reduce biological ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical ...
Why lasting weight maintenance requires more than calorie control, integrating diet quality, movement, circadian biology, ...
Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalInitiation of the ...
MedPage Today on MSN
DVT Assessment Strategy Safely Expands Rule-Out
A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...
Tea may offer powerful health benefits, but how it is prepared and consumed matters. Tea has a long history as both a ...
Glass Cannon Pictos are special combat modifiers that boost offensive stats such as raw damage, critical chance, or ability ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As compared with fulvestrant alone, the combination more than doubled the median ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Applic ...
This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...
Similarly, since the late-1990s Toronto has been enjoying another boom, which has resulted in entirely new districts, such as ...
New members bring deep experience in pancreatic, colorectal, and anal cancers to guide pelareorep’s development as a platform immunotherapy across GI tumorsCompany continues to strengthen its clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results